Migraines In Women: How Hormones Influence Neurological Health
For those who have not experienced a migraine, perhaps it would seem just another headache. But for someone like me who has suffered through migraines that will last over a week even with medication, I can definitely tell you that it's much more. The ache is not confined to the head; it's the whole experience. Nausea, sensitivity to light, and throbs so bad it makes simple tasks unbearable. It also comes with an emotional burden—the loneliness and frustration are pretty unbearable. Through the years, realizing how hormones are also implicated in triggering and exacerbating my migraines has helped change the game in my dealing with these episodes.
Hormonal migraines are caused by fluctuations in estrogen and progesterone, the two main female hormones. These hormones are essential for the reproductive system, regulating menstrual cycles and pregnancy. They also have an effect on brain chemicals, such as serotonin and dopamine, which affect mood and pain perception. When hormone levels fluctuate, such as during menstruation, pregnancy, or menopause, they can destabilize the pathways in the brain, causing migraines.
According to Dr. Shivananda Pai, Consultant Neurology, migraines are more than a neurological disorder. "Migraines represent a complex interplay of genetic, environmental, and hormonal factors. In women, hormonal fluctuations are a critical trigger that amplifies sensitivity to pain," he explains. Hormonal headaches are particularly challenging because they are influenced by multiple life stages, from puberty to post-menopause. Common causes include:
Estrogen, often called the "hormone of femininity", does more than regulate reproductive functions. It is a powerful influencer of brain health. Estrogen modulates the activity of neurotransmitters like serotonin, which regulates mood and pain perception, and dopamine, associated with reward and pleasure.
During stages of hormonal stability, like in pregnancy's latter months, women may have fewer migraines because of the steady elevation of estrogen. However, a sudden downfall in estrogen destabilizes these chemicals in the brain, sending a heightened sensitivity for migraine triggers.
The most common form of hormonal migraines is menstrual migraines, which occur in response to the steep decline in estrogen levels just before menstruation. These are typically more intense and less responsive to standard treatment. The timing of these migraines provides clear evidence of the role hormones play in neurological health.
Pregnancy is a rollercoaster of hormones. Although many women experience relief from migraines as a result of the constantly elevated levels of estrogen, some women, particularly in the first trimester, worsen. This individual variability is a characteristic of hormonal migraine triggers.
Hormonal treatments, such as oral contraceptives and HRT, have had mixed reviews regarding their use in managing migraine. Some women fare better with the stabilization the treatment provides, whereas others suffer worsening symptoms. This will depend on the nature and dose of the hormones used.
For most women, menopause brings relief from their migraines. The decline in frequency and severity often accompanies stability in hormone levels. Even so, the susceptibility remains with some towards other forms of triggers including stress and sleep deprivation, not to forget diet-related factors and continues the saga of migraines well after the menopausal stages.
The relationship of hormones to neurological health goes beyond migraines. Hormonal changes have profound effects on a woman's brain in general.
Mood Disorders: Estrogen helps stabilize mood by regulating serotonin. Its decline at menopause increases the risk of mood swings and depression.
Neurodegenerative Diseases: Estrogen is neuroprotective, stimulating the growth and repair of brain cells. Its absence in post-menopausal women has been associated with an increased risk of Alzheimer's disease and cognitive decline.
Multiple Sclerosis (MS): Hormonal cycles may affect the course of MS, a disease that occurs more frequently in women than in men. Estrogen's anti-inflammatory effects provide transient protection during pregnancy, reducing relapse rates in women with MS.
"The intricate interplay between hormones and neurological health underscores the need for gender-specific treatment approaches," says Dr. Pai.
While hormonal changes are inevitable, several strategies can help manage migraines effectively:
Understanding your menstrual cycle can help identify patterns and predict when migraines might occur. This knowledge allows for preventive measures, such as scheduling medications or adjusting lifestyle habits.
Working with a neurologist or gynecologist can help develop a personalized treatment plan. Options might include hormonal therapies, triptans, or preventive medications tailored to your specific needs.
A well-balanced diet, regular exercise, and stress management are all integral parts of managing migraines. For instance, magnesium-rich foods and hydration can help reduce the frequency and severity of attacks.
For people with severe or frequent migraines, preventive medications, such as beta-blockers or CGRP inhibitors, may be prescribed. These medications stabilize brain activity and therefore reduce the chances of migraine during hormonal fluctuations.
Techniques like yoga, meditation, and biofeedback can enhance wellness and reduce the debilitating effects of stress-one of the most common migraine triggers.
Research that was once in its embryonic stage continues to shed more light on the role of hormones in migraines and other neurological conditions. Further breakthroughs in genetic testing might enable doctors to predict, at least in a way, how an individual would react to hormonal therapies. The importance of gender-specific approaches is gradually being realized, which involves differentiating between the plight of women with migraines from others.
As Dr. Pai puts it, "Empowering women with knowledge about the hormonal underpinnings of migraines can lead to better, more personalized care. With the right strategies, migraines can be effectively managed, allowing women to lead fuller, healthier lives.
Migraines are not headaches; they are a complex neurological condition that deeply impacts the lives of millions of women. Understanding the role of hormones in triggering and exacerbating migraines is a vital step toward better management and relief.
Awareness, proactive care, and advances in medical research can help women regain their lives from the grip of hormonal migraines. Whether tracking cycles, adopting healthier habits, or seeking tailored medical care, every step taken toward understanding and managing migraines is a step toward empowerment.
Dr Shivananda Pai is a Consultant Neurology at KMC Hospital Dr B R Ambedkar Circle in Mangalore, India.
Brandes JL. The Influence of Estrogen on Migraine: A Systematic Review. JAMA. 2006;295(15):1824–1830. doi:10.1001/jama.295.15.1824
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012 Apr;13(3):177-89. doi: 10.1007/s10194-012-0424-y. Epub 2012 Feb 26. PMID: 22367631; PMCID: PMC3311830.
Credit: AI
As we brace ourselves for another bout of winter, we can’t help but feel wary about the changes the dip in temperature brings on our mood and mental well-being. You are not imagining winter depression when you start to feel sudden loss of joy.
Seasonal depression is more than feeling gloomy. You may no longer enjoy the activities you once relished, like listening to music, exercising or meeting friends. This isn’t just another effect of winter. Experts have designated a term for it: anhedonia.
Anhedonia refers to the loss of pleasure or interest in something you once enjoyed. It is one of the symptoms of depression, including seasonal affective disorder (SAD). Unlike sadness, anhedonia can render someone feeling disconnected with or indifferent towards things they once enjoyed.
A person experiencing anhedonia may still participate in activities they enjoy but will no longer reap emotional rewards from it.
“Anhedonia is not the kind of sadness where you’re feeling down but still have moments of enjoyment,” Dr Deeksha Kalra, Associate Consultant, Psychiatry, Artemis Hospital, Gurugram, explained to HealthandMe.
Dr Samant Darshi, Consultant Psychiatrist and Neuromodulation Expert at Yatharth Hospitals, told us, “While sadness entails the state of feeling unhappy about something, anhedonia pertains to the lack of enjoyment.”
Dr Kalra said, during SAD, anhedonia may be experienced during the affected season like winter.
“This can happen at the same time as low mood, but it can also be one of the clearest symptoms. In SAD, these changes are usually present during the affected season and resolve with the resolution of the depressive episode. So anhedonia is about muted pleasure, not just feeling sad,” Dr Kalra explains.
Changes that come with SAD, a type of depressive phase, usually pertains to specific seasons, like mostly winter. Due to less duration of daylight, the body’s internal clock, known as circadian rhythm, may get affected. Along with circadian rhythm, poor diet, irregular sleep pattern and limited physical activity can also contribute to SAD.
This could cause one to feel difficult to initiative activities they enjoy as they no longer feel motivated, affecting the brain reward system.
“Seasonal affective disorder (SAD) causes disturbance of mood, sleep, energy, and motivation. Activities which were pleasurable before become less rewarding because of this. The changes in daylight hours may affect the body clock or the physiological processes related to mood control. The decrease in energy and motivation makes doing the activity even harder and less pleasurable,” said Dr Darshi.
Dr Kalra explains that there are a lot of phases to experiencing ‘enjoyment’. It involves identifying something rewarding, anticipating it, experiencing pleasure and learning from the experience. Depression can affect all these phases, making previously enjoyable activities feel less rewarding.
“Brain networks including the striatum and nucleus accumbens, contribute to the valuation of rewarding experiences and the motivation of behavior. When their responses are dulled and something that was once naturally rewarding may not have the same emotional resonance,” she says.
Also read: Children’s Mental Health Often Goes Unnoticed: Can India’s New School Policy Change That?
Dopamine is a neurotransmitter in the brain responsible for motivation, rewards, learning, and directing behaviour as per goals. When we talk about SAD and anhedonia, dopamine comes into the picture as it is related to motivation and rewards.
Dr Kalra explained, “Dopamine is involved in motivation, reward anticipation, learning and determining the value of pursuing something. That’s why dopamine has been looked at when researchers have investigated anhedonia and low motivation.”
But doctors say that anhedonia is not characterised by shortage of dopamine. According to research, SAD has been reported to affect dopamine signalling, including lower dopamine transporter availability in the striatum during symptomatic depression.
Dr Darshi also emphasises that dopamine is only a part of the process.
He said, “Studies concerning depression and anhedonia indicate that changes in the activity of dopamine result in the decrease in motivation and reward sensitivity. However, anhedonia encompasses many brain processes.”
Also read: Self-Diagnosis Could Go Wrong: Are We Overusing The Words Anxiety, Trauma and ADHD?
Anhedonia makes one indifferent by directly affecting the anticipatory pleasure mechanism. Anticipatory pleasure is the excitement one feels before an event. Consummatory pleasure is the enjoyment experienced while the event is in progress.
“Anhedonia can affect the anticipatory pleasure you feel when you look forward to something and the consummatory pleasure you experience when it actually happens. Someone might know that a favorite meal, holiday or meeting with friends should be enjoyable but feel little excitement beforehand. The pleasure might also feel weaker than expected when the event happens,” Dr Kalra explains.
Everyone with SAD experiences anhedonia in different ways. While some may lose interest and pleasure, others may withdraw socially, sleep excessively, eat more, feeling more tired among other symptoms.
“SAD doesn’t affect everybody in exactly the same way any more than depression is a single biological process. Different people can experience different combinations of changes in mood regulation, circadian rhythms, sleep, appetite and energy and reward processing,” says Dr Kalra.
She also said that multiple symptoms may interact. For example, poor sleep could result into daytime sluggishness, making energetic activities less tempting.
Dr Darshi explained, “Individuals with SAD have different presentations since biology, genetics, circadian rhythm, and psychology are unique for each person. Some individuals have disturbances in reward and motivation, whereas others have sleep disturbances or carbohydrate cravings, or even fatigue. Symptoms might be overlapping and are a reflection of various underlying mechanisms.”
Credit: iStock
Female breast cancer was the most commonly diagnosed cancer among women in India in 2024, with an estimated 237,231 new cases and 96,100 deaths, according to the International Agency for Research on Cancer (IARC).
Despite the importance of early detection, screening uptake remains low. Experts say India needs better access to screening and approaches tailored to age, breast density and individual risk.
Dr. Sandeep Nayak, Chairman of Oncology at MACS-Renova Oncology Institute, KIMS Hospital, Bengaluru, told HealthandMe that population-wide screening remains a distant goal, with opportunistic screening still the norm.
“Because of this, applying blanket Western guidelines is ineffective. We need a pragmatic, age-stratified approach to imaging: utilizing breast ultrasound (USG) for women aged 35 to 45—where dense breast tissue severely limits mammogram sensitivity—and reserving routine mammography for women above 50, where tissue density decreases and diagnostic yield peaks,” he said.
Also read: World Breast Cancer Day 2026: Life After Breast Cancer, The Fear No One Sees
“The alarming epidemiological paradox is that while our incidence is a third of Western nations, our death rate already surpasses theirs. The issue is not that this cancer has an aggressive biology in India; it is the timeline of discovery,” said Dr. Navin Gnanasekaran, Head of Clinical Services, Radiology and Interventional Radiology for the Apollo Group Chennai Region.
Dr. Gnanasekaran said more than 60% of breast cancers in the United States are diagnosed while still localized, with five-year survival exceeding 90%. In India, many cases are detected after the cancer has spread beyond the breast, contributing to a five-year survival rate of 66.4%, he said.
India introduced population-based screening for common noncommunicable diseases in 2016 under the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), launched in 2010. The program includes breast cancer screening among women aged 30 and above.
However, National Family Health Survey-5 (NFHS-5) data show that only 0.9% of women aged 30–49 had ever undergone a breast examination for cancer detection. Dr. Gnanasekaran placed the median age of breast cancer onset in India at around 45.
Read More: Ozempic-Like Weight-Loss Drugs May Cut Breast Cancer Risk By A Third, Finds Research
Experts differ when routine mammography should begin and whether breast density should influence imaging choices.
Dr. Gnanasekaran recommended digital mammography every two years for women aged 40–60. He proposed linking screening reminders to Ayushman Bharat Health Account (ABHA) IDs, deploying mobile mammography units in rural areas and using validated artificial intelligence (AI) to help interpret scans.
Dr. Nayak recommended ultrasound for women aged 35–45 and routine mammography for those above 50.
Dense breast tissue can make some cancers harder to detect on mammograms. Women at high genetic risk, including those with BRCA mutations or a strong family history, may need earlier surveillance, potentially including contrast-enhanced breast MRI in their late 20s or early 30s, depending on individual risk.
Dr. Gnanasekaran stressed that screening must be supported by accessible diagnostic and treatment services, including timely biopsies.
Mammography can miss some cancers, particularly in women with dense breasts. Ultrasound may be added for dense breasts or specific concerns, while MRI is generally used for women at higher risk or in selected situations.
Dr. Garvit Chitkara, Associate Director of Breast Surgical Oncology and Oncoplasty at Nanavati Max Institute of Cancer Care, Mumbai, said the radiation risk from mammography is low, while false-positive results can lead to additional tests.
“At the recommended intervals, mammography does not meaningfully raise your cancer risk. The more real downsides are occasional false alarms that lead to extra tests, which is a reason to have it done at a good centre and discuss any call-back with your doctor,” he told HealthandMe.
A normal mammogram should not be used to dismiss a persistent lump or other breast symptoms. Women experiencing changes should seek medical evaluation even if their most recent screening result was normal.
Many breast lumps are benign, including cysts and fibroadenomas, but touch alone cannot reliably distinguish a harmless lump from cancer.
“Any new lump, or a lump that is changing in size or feel, should be examined by a doctor. A quick check usually settles it and gives you peace of mind,” Dr. Chitkara said.
Persistent redness, itching or skin thickening, breast dimpling, puckering, an orange-peel texture, nipple retraction or unusual nipple discharge should also be evaluated.
Early breast cancer is often painless. Women should not wait for pain before seeking medical attention.
Credit: iStock
Molly, a head nurse at a leading city hospital, was diagnosed with breast cancer. Chemotherapy and surgery helped her overcome the disease, but 26 years later, it resurfaced during a routine examination. By then, the experience had faded from the minds of many, including her family.
Molly is not alone. Filmmaker and author Tahira Kashyap was diagnosed with Stage 0 breast cancer, or ductal carcinoma in situ (DCIS), in 2018. She underwent a mastectomy, followed by systemic therapies and chemotherapy. In 2025, she revealed that her cancer had relapsed after seven years.
“Round 2 for me... I still got this,” she wrote, emphasizing the importance of routine screening and regular mammograms.
In 2024, breast cancer caused an estimated 694,000 deaths and 2.4 million new cases worldwide, making it the most commonly diagnosed cancer among women in 164 of 186 countries.
“The last chemotherapy session or final radiation appointment may mark the end of active breast cancer treatment. But for many women, the fear does not end there. ‘What if the cancer comes back?’ can remain an unsettling companion, even on the happiest days,”
Prof. Jyoti Bajpai, Director – Medical, Precision & Immuno-Oncology, Apollo Hospitals, Mumbai & Western Zone, told HealthandMe.
Despite advances in screening and treatment, completing treatment does not mean an immediate return to normal life. As hospital visits become less frequent, friends and family may assume the hardships are over. But survivorship can mark the beginning of a quieter struggle with fear, uncertainty and adapting to a changed body and mind, added Dr. Randeep Singh, Director and Senior Consultant, Oncology Services, Medical Oncology, Haemato-Oncology & BMT, Narayana Hospital, Gurugram.
Fatigue, joint pain, menopausal symptoms and changes in body image may persist after treatment, Prof. Jyoti noted. Every ache can trigger anxiety, while follow-up appointments can revive old fears.
Restrictive diets, conflicting advice and misinformation can complicate everyday decisions. The pressure to resume family and professional responsibilities may also leave little room for emotional distress.
An Indian study led by the Kidwai Memorial Institute of Oncology in Karnataka and presented at the 2026 ASCO Annual Meeting found that 43% of breast cancer survivors reported persistent fatigue and reduced physical activity, while 71% reported financial concerns.
Dr. Randeep described fear of recurrence as one of the most challenging aspects of survivorship.
“Fear of recurrence is one of the most challenging aspects of survivorship. Survivors still may be concerned about the bumps, aches, and pains they experience that are different from those they are used to. You may start to think of things that cause you fear and anxiety: How can it be that I just have a headache, but how can it be that the cancer has returned?”
Scans, blood tests and follow-up visits can also be emotionally draining.
“There may be worry or stress that is hard to describe to someone who's never been through it before. To a survivor, it can be a reminder of all the things that have happened to her and all the things she fears. This worry is not a weakness. The journey from cancer survivor can alter someone's notion of safety, health and the future.”
Changes in appearance can affect self-confidence, Dr. Randeep told HealthandMe. Hair may regrow differently, scars may remain, and the loss or reshaping of a breast can change how a woman feels about her body. Physical discomfort, diminished libido or reduced attraction to a partner may also affect intimacy.
“These experiences are so personal. A woman may be thankful to be alive and at the same time mourn the body, energy, or normalcy she had prior to her cancer diagnosis. Both emotions can be experienced at the same time and neither lessens her strength,” he said.
During treatment, support may come through phone calls, hospital visits, meals and messages of encouragement. Once treatment ends, that attention can fade as people assume the survivor is fine.
Survivors may also feel pressured to remain positive, particularly when others remind them how fortunate they are to have survived. They may suppress anxiety, sadness or frustration to avoid worrying their families.
Cancer care must extend beyond controlling the disease, said Prof. Jyoti Bajpai, Founder & President-Elect of the Immuno-Oncology Society of India (I-OSI) and Asia Co-Chair of the Society for Immunotherapy of Cancer (SITC).
Alongside appropriate surveillance and management of physical symptoms, women need evidence-based guidance, nutritional support and psychological care. Families must recognize that recovery is individual and that fear of recurrence deserves compassion, not dismissal.
Family and friends, counsellors and breast cancer survivor groups can provide emotional support. Healthy habits, gentle physical activity, adequate rest and honest conversations with healthcare professionals can also help survivors cope. Persistent anxiety, depression or physical symptoms should not be ignored; medical or psychological help should be sought when needed.
Survivorship is a process of rebuilding trust, finding happiness and accepting an uncertain future. The goal is not merely to help women live beyond cancer, but to give them the support, understanding and confidence to live fully again.
“No woman should have to navigate that journey alone,” Dr. Jyoti said.
© $2026 Times Horizon Private Limited